<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02854410</url>
  </required_header>
  <id_info>
    <org_study_id>changsm2005</org_study_id>
    <nct_id>NCT02854410</nct_id>
  </id_info>
  <brief_title>Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients</brief_title>
  <official_title>Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients Pre and Post Concurrent Chemo-radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cancer Institute and Hospital, Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether dietary nitrate supplementation could
      improve the salivary flow for nasopharyngeal carcinoma patients receiving concurrent
      chemo-radiation therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty patients diagnosed as nasopharyngeal carcinoma will be recruited. Nitrate
      supplement(Sodium nitrate: 0.5 mmol/kgbodyweight,bid) or placebo(sodium chloride: 0.5
      mmol/kgbodyweight,bid) will be provided to the patients from 7 days before radiotherapy to
      one month after the finish of radiotherapy . The salivary flow and plasma nitrate levels will
      be determined before the course of nitrate supplementation and radiotherapy,before the course
      of radiotherapy,post the course of radiotherapy immediately and one month after the finish of
      radiotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of salivary flow</measure>
    <time_frame>one day before the course of nitrate supplementation and radiotherapy,one day before the course of radiotherapy,one day post the course of radiotherapy and one month after the finish of radiotherapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chang of plasm nitrate level</measure>
    <time_frame>one day before the course of nitrate supplementation and radiotherapy,one day before the course of radiotherapy,one day post the course of radiotherapy and one month after the finish of radiotherapy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Nasopharyngeal Carcinoma</condition>
  <arm_group>
    <arm_group_label>Sodium nitrate supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive Sodium nitrate supplementation from 7 days before radiotherapy to one month after the end of radiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator(sodium chloride)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive placebo from 7 days before radiotherapy to one month after the end of radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sodium nitrate</intervention_name>
    <description>Dietary intake:Sodium nitrate 0.5mmol/kgbodyweight,bid</description>
    <arm_group_label>Sodium nitrate supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <description>Dietary intake:sodium chloride 0.5mmol/kgbodyweight,bid</description>
    <arm_group_label>Placebo Comparator(sodium chloride)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with newly diagnosed stages III-IVb (UICC 2002) nasopharyngeal carcinomas,
             will be recruited.

        Exclusion Criteria:

          -  Patients with local invasion or metastatic foci in salivary glands, detected by MRI
             and positron emission computed tomography(PET-CT) prior to treatment, were excluded,
             as were patients suffering from diseases, such as Sjogren's syndrome, or with a
             history of surgery to major salivary glands, or prior head and neck radiotherapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wang Songlin, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Capital Medical University shool of stomatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chang Shimin, PHD</last_name>
    <phone>13520538923</phone>
    <email>changsm2005@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Capital Medical University School of Stomatology</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Xia DS, Deng DJ, Wang SL. Destruction of parotid glands affects nitrate and nitrite metabolism. J Dent Res. 2003 Feb;82(2):101-5.</citation>
    <PMID>12562881</PMID>
  </reference>
  <reference>
    <citation>Xia DS, Liu Y, Zhang CM, Yang SH, Wang SL. Antimicrobial effect of acidified nitrate and nitrite on six common oral pathogens in vitro. Chin Med J (Engl). 2006 Nov 20;119(22):1904-9.</citation>
    <PMID>17134590</PMID>
  </reference>
  <reference>
    <citation>Xia D, Deng D, Wang S. Alterations of nitrate and nitrite content in saliva, serum, and urine in patients with salivary dysfunction. J Oral Pathol Med. 2003 Feb;32(2):95-9.</citation>
    <PMID>12542832</PMID>
  </reference>
  <reference>
    <citation>Bryan NS, Ivy JL. Inorganic nitrite and nitrate: evidence to support consideration as dietary nutrients. Nutr Res. 2015 Aug;35(8):643-54. doi: 10.1016/j.nutres.2015.06.001. Epub 2015 Jun 11. Review.</citation>
    <PMID>26189149</PMID>
  </reference>
  <reference>
    <citation>Xia D, Qu X, Tran SD, Schmidt LL, Qin L, Zhang C, Cui X, Deng D, Wang S. Histological characteristics following a long-term nitrate-rich diet in miniature pigs with parotid atrophy. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6225-34. eCollection 2015.</citation>
    <PMID>26261499</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2016</study_first_submitted>
  <study_first_submitted_qc>July 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2016</study_first_posted>
  <last_update_submitted>July 31, 2016</last_update_submitted>
  <last_update_submitted_qc>July 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Songlin Wang</investigator_full_name>
    <investigator_title>Professor and Vice President of Capital Medical University</investigator_title>
  </responsible_party>
  <keyword>dietary sodium nitrate</keyword>
  <keyword>radiotherapy</keyword>
  <keyword>nasopharyngeal carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Nasopharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

